Fischer Medical Ventures Schedules Board Meeting for Q2 FY27 Financial Results
Fischer Medical Ventures Ltd 路 Intimation 路 14 Nov 2026, 5:30 am
Fischer Medical Ventures Schedules Board Meeting for Q2 FY27 Financial Results Fischer Medical Ventures Limited announced that its Board of Directors will meet on 14th Nov'26 via video conferencing to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. In compliance with insider trading regulations, the trading window for dealing in company equity shares has been closed since 25th Sep'26 and will remain shut until 48 hours following the official declaration of the financial results.
Original exchange filing (PDF)
More announcements from Fischer Medical Ventures Ltd
- Financial results for the quarter and half year ended 30th Sept 2026 路 15 Nov 2026
- Outcome of Board Meeting held on 14th Nov 2026 for approval of Q2 financials 路 15 Nov 2026
- Fischer Medical Ventures Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 15 Nov 2026
- The Monitoring Agency Report for the quarter ended 30 September 2026 is enclosed. 路 14 Nov 2026
- Fischer Medical Ventures Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 14 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 14 Nov 2026
- Appointment of Mr Chan Sing En as an Independent Director of FMV Global Innovations Pte.Ltd, Singapore, a Material Wholly Owned Subsidiary Company 路 27 Oct 2026
- Postal Ballot Notice & Scrutinizer 路 14 Oct 2026
